Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b).
paper
Cited
Public
Unavailable
- Authors
- Jasper, J R; Kosaka, A; To, Z P; Chang, D J; Eglen, R M
- Year
- 1997
- Journal
- British journal of pharmacology
- PMID
- 9298538
- DOI
- 10.1038/sj.bjp.0701336
- PMCID
- PMC1564895
1. The rat 5-hydroxytryptamine (5-HT)7 receptor displays two splice variations, a long form, and a truncated splice isoform, arising from the introduction of a stop codon near the carboxy-terminus. The human-5HT7 receptor gene contains at least two introns and encodes a 445 amino acid 5-HT receptor. 2. A truncated splice variation in the human 5-HT7 receptor was isolated from a human placental cDNA library. In accordance with current NC-IUPHAR nomenclature guidelines, it is suggested that this receptor be donated as the h5-HT7b receptor and the long form of the receptor as h5-HT7a. 3. The h5-HT7b receptor was stably expressed in HEK 293 cells and ligand affinities were determined by displacement of [3H]-5-carboxyamidotryptamine (5-CT; Kd = 0.28 +/- 0.6 nM, Bmax = 7.3 +/- 17 pmol mg-1 protein). The rank order of affinities (pKi) for a series of ligands was: 5-carboxamidotryptamine (5-CT, 9.65) > 5-hydroxytryptamine (5-HT, 9.41) > methiothepin (8.87) > mesulergine (7.87) > 8-hydroxy-2 (di-n-propylamino)tetralin (8-OH-DPAT, 6.85) > ketanserin (6.44). 4. The h5-HT7b receptor coupled positively to adenylyl cyclase in HEK 293 cells. This response was elicited by a number of agonists with the following order of potency (pEC50): 5-CT (8.7 +/- 0.11) > 5-MeOT (5-methoxytryptamine; 8.1 +/- 0.20) > 5-HT (7.5 +/- 0.13) tryptamine (5.6 +/- 0.36) > 8-OH-DPAT (5.3 +/- 0.28) > 5-methoxytryptamine (5.0 +/- 0.06). This rank order was comparable to that observed in the radioligand binding studies. 5. In a similar fashion to that described for the 5-HT7a receptor, PCR studies suggested that the 5-HT7b receptor mRNA is found in great abundance throughout the brain, in the small intestine and aorta. 6. It is concluded that the h5-HT7 receptor, like the rat receptor, exists as splice variants exhibiting similar pharmacology, signal transduction and distribution. It is thus likely that there exists a complex physiological role for alternate splicing products of the 5-HT7 receptor gene.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genome-wide association study of theta band event-related oscillations identifies serotonin receptor gene HTR7 influencing risk of alcohol dependence. | 2011 | 21184583 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| "Selective" serotonin 5-HT<sub>2A</sub> receptor antagonists. | Casey AB et al. | β | 2022 | β |
| Alternative Pre-mRNA Splicing of the Mu Opioid Receptor Gene, <i>OPRM1</i>: Insight into Complex Mu Opioid Actions. | Liu S et al. | β | 2021 | β |
| An inactive receptor-G protein complex maintains the dynamic range of agonist-induced signaling. | Jang W et al. | β | 2020 | β |
| Role of 5-HT<sub>7</sub> receptors in the immune system in health and disease. | Quintero-Villegas A et al. | β | 2019 | β |
| Long-Term Citalopram Treatment Alters the Stress Responses of the Cortical Dopamine and Noradrenaline Systems: the Role of Cortical 5-HT1A Receptors. | Kaneko F et al. | β | 2016 | β |
| Whole genome sequencing of a dizygotic twin suggests a role for the serotonin receptor HTR7 in autism spectrum disorder. | Helsmoortel C et al. | β | 2016 | β |
| Alternative Splicing of G Protein-Coupled Receptors: Relevance to Pain Management. | Oladosu FA et al. | β | 2015 | β |
| HCN channels contribute to serotonergic modulation of ventral surface chemosensitive neurons and respiratory activity. | Hawkins VE et al. | β | 2015 | β |
| Molecular underpinnings of ventral surface chemoreceptor function: focus on KCNQ channels. | Mulkey DK et al. | β | 2015 | β |
| Serotonergic regulation of excitability of principal cells of the dorsal cochlear nucleus. | Tang ZQ et al. | β | 2015 | β |
| Serotonin and sensory nerves: meeting in the cardiovascular system. | Watts SW | β | 2014 | β |
| Synthesis and pharmacological evaluation of optically pure, novel carbonyl guanidine derivatives as dual 5-HT2B and 5-HT7 receptor antagonists. | Moritomo A et al. | β | 2014 | β |
| Synthesis and structure-activity relationships of new carbonyl guanidine derivatives as novel dual 5-HTβB and 5-HTβ receptor antagonists. Part 2. | Moritomo A et al. | β | 2014 | β |
| Synthesis, radiolabeling and in vivo evaluation of [(11)C](R)-1-[4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl]-3-(2-pyrazinyloxy)-2-propanol, a potential PET radioligand for the 5-HT(7) receptor. | Hansen HD et al. | β | 2014 | β |
| The effects of new sigma (Ο) receptor ligands, PB190 and PB212, in the models predictive of antidepressant activity. | Skuza G et al. | β | 2014 | β |
| Development of 3,4-dihydroisoquinolin-1(2H)-one derivatives for the Positron Emission Tomography (PET) imaging of Οβ receptors. | Abate C et al. | β | 2013 | β |
| Neuronal control of pedal sole cilia in the pond snail Lymnaea stagnalis appressa. | Longley RD et al. | β | 2013 | β |
| Serotonergic mechanisms are necessary for central respiratory chemoresponsiveness in situ. | Corcoran AE et al. | β | 2013 | β |
| Synthesis and structure-activity relationships of new carbonyl guanidine derivatives as novel dual 5-HT2B and 5-HT7 receptor antagonists. | Moritomo A et al. | β | 2013 | β |
| The arylpiperazine derivatives N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide and N-benzyl-4-(2-diphenyl)-1-piperazinehexanamide exert a long-lasting inhibition of human serotonin 5-HT7 receptor binding and cAMP signaling. | Atanes P et al. | β | 2013 | β |
| Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo. | Lacivita E et al. | β | 2012 | β |
| Serotonin (5-HT7) receptor-stimulated activation of cAMP-PKA pathway in bovine corneal epithelial and endothelial cells. | Grueb M et al. | β | 2012 | β |
| Genome-wide association study of theta band event-related oscillations identifies serotonin receptor gene HTR7 influencing risk of alcohol dependence. | Zlojutro M et al. | β | 2011 | β |
| A novel corticotropin-releasing factor receptor splice variant exhibits dominant negative activity: a putative link to stress-induced heart disease. | Sztainberg Y et al. | β | 2009 | β |
| Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene. | Xu J et al. | β | 2009 | β |
| 5-HT(7) receptors in the modulation of cognitive processes. | Cifariello A et al. | β | 2008 | β |
| Molecular biology of 5-HT receptors. | Hannon J et al. | β | 2008 | β |
| Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders. | Heal DJ et al. | β | 2008 | β |
| Serotonin pharmacology in the gastrointestinal tract: a review. | Beattie DT et al. | β | 2008 | β |
| Structural modifications of N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides: influence on lipophilicity and 5-HT7 receptor activity. Part III. | Leopoldo M et al. | β | 2008 | β |
| Bivalent ligand approach on 4-[2-(3-methoxyphenyl)ethyl]-1-(2-methoxyphenyl)piperazine: synthesis and binding affinities for 5-HT(7) and 5-HT(1A) receptors. | Leopoldo M et al. | β | 2007 | β |
| Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties. | Rauly-Lestienne I et al. | β | 2007 | β |
| Novel interaction between the human 5-HT7 receptor isoforms and PLAC-24/eIF3k. | De Martelaere K et al. | β | 2007 | β |
| Structure-activity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents. 2. | Leopoldo M et al. | β | 2007 | β |
| 5-hydroxytryptamine receptors in the human cardiovascular system. | Kaumann AJ et al. | β | 2006 | β |
| Monoamine receptors in human corneal epithelium and endothelium. | Grueb M et al. | β | 2006 | β |
| Reanalysis of constitutively active rat and human 5-HT7(a) receptors in HEK-293F cells demonstrates lack of silent properties for reported neutral antagonists. | Romero G et al. | β | 2006 | β |
| Differential agonist-mediated internalization of the human 5-hydroxytryptamine 7 receptor isoforms. | Guthrie CR et al. | β | 2005 | β |
| Evidence for 5-HT2B and 5-HT7 receptor-mediated relaxation in pulmonary arteries of weaned pigs. | JΓ€hnichen S et al. | β | 2005 | β |
| Glycogen metabolism in rat ependymal primary cultures: regulation by serotonin. | Verleysdonk S et al. | β | 2005 | β |
| Molecular analysis of the interaction between the intracellular loops of the human serotonin receptor type 6 (5-HT6) and the alpha subunit of GS protein. | Kang H et al. | β | 2005 | β |
| Novel 3-aminochromans as potential pharmacological tools for the serotonin 5-HT(7) receptor. | Holmberg P et al. | β | 2005 | β |
| Paroxetine is effective in desensitizing 5-HT1A receptor function in adult offspring exposed prenatally to cocaine. | Chen Z et al. | β | 2005 | β |
| Serotonin 5-HT7 receptors coupled to induction of interleukin-6 in human microglial MC-3 cells. | MahΓ© C et al. | β | 2005 | β |
| 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents. | Hedlund PB et al. | β | 2004 | β |
| Autoradiographic distribution of 5-HT7 receptors in the human brain using [3H]mesulergine: comparison to other mammalian species. | MartΓn-Cora FJ et al. | β | 2004 | β |
| Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors. | MahΓ© C et al. | β | 2004 | β |
| Functional expression of the serotonin 5-HT7 receptor in human glioblastoma cell lines. | MahΓ© C et al. | β | 2004 | β |
| Inhibition of bladder activity by 5-hydroxytryptamine1 serotonin receptor agonists in cats with chronic spinal cord injury. | Gu B et al. | β | 2004 | β |
| Opposing electrophysiological actions of 5-HT on noncholinergic and cholinergic neurons in the rat ventral pallidum in vitro. | Bengtson CP et al. | β | 2004 | β |
| Serotonergic regulation of membrane potential in developing rat prefrontal cortex: coordinated expression of 5-hydroxytryptamine (5-HT)1A, 5-HT2A, and 5-HT7 receptors. | Béïque JC et al. | β | 2004 | β |
| Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents. | Leopoldo M et al. | β | 2004 | β |
| Studies on 1-arylpiperazine derivatives with affinity for rat 5-HT7 and 5-HT1A receptors. | Leopoldo M et al. | β | 2004 | β |
| Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7). | Glennon RA | β | 2003 | β |
| Impairment of signal transduction in response to stimulation of the naturally occurring Pro279Leu variant of the h5-HT7(a) receptor. | Kiel S et al. | β | 2003 | β |
| No hypothermic response to serotonin in 5-HT7 receptor knockout mice. | Hedlund PB et al. | β | 2003 | β |
| Unaltered agonist potency upon inducible 5-HT7(a) but not 5-HT4(b) receptor expression indicates agonist-independent association of 5-HT7(a) receptor and Gs. | Bruheim S et al. | β | 2003 | β |
| 2a-[4-(Tetrahydropyridoindol-2-yl)butyl]tetrahydrobenzindole derivatives: new selective antagonists of the 5-hydroxytryptamine7 receptor. | Kikuchi C et al. | β | 2002 | β |
| [3H]-SB-269970 radiolabels 5-HT7 receptors in rodent, pig and primate brain tissues. | Thomas DR et al. | β | 2002 | β |
| 5-HT7 receptors modulate synchronized network activity in rat hippocampus. | Gill CH et al. | β | 2002 | β |
| An RT-PCR study of 5-HT(6) and 5-HT(7) receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia. | East SZ et al. | β | 2002 | β |
| Double-blind, placebo-controlled study of single-dose metergoline in depressed patients with seasonal affective disorder. | Turner EH et al. | β | 2002 | β |
| DR4004, a putative 5-HT(7) receptor antagonist, also has functional activity at the dopamine D2 receptor. | Kogan HA et al. | β | 2002 | β |
| Molecular, pharmacological and functional diversity of 5-HT receptors. | Hoyer D et al. | β | 2002 | β |
| Serotonin suppresses the slow afterhyperpolarization in rat intralaminar and midline thalamic neurones by activating 5-HT(7) receptors. | Goaillard JM et al. | β | 2002 | β |
| Smooth muscle 5-HT2A receptors mediating contraction of porcine isolated proximal stomach strips. | Janssen P et al. | β | 2002 | β |
| The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects. | Krobert KA et al. | β | 2002 | β |
| High-affinity interactions of ligands at recombinant guinea pig 5HT7 receptors. | Wilcox RE et al. | β | 2001 | β |
| Multiplicity of mechanisms of serotonin receptor signal transduction. | Raymond JR et al. | β | 2001 | β |
| Role of 5-HT(1A) and 5-HT(7) receptors in the facilitatory response induced by 8-OH-DPAT on learning consolidation. | Meneses A et al. | β | 2001 | β |
| The effect of SB-269970, a 5-HT(7) receptor antagonist, on 5-HT release from serotonergic terminals and cell bodies. | Roberts C et al. | β | 2001 | β |
| [(3)H]-SB-269970--A selective antagonist radioligand for 5-HT(7) receptors. | Thomas DR et al. | β | 2000 | β |
| 5-HT7 receptors: current knowledge and future prospects. | Vanhoenacker P et al. | β | 2000 | β |
| Antagonist activity of meta-chlorophenylpiperazine and partial agonist activity of 8-OH-DPAT at the 5-HT(7) receptor. | Wood M et al. | β | 2000 | β |
| Evidence that G(z)-proteins couple to hypothalamic 5-HT(1A) receptors in vivo. | Serres F et al. | β | 2000 | β |
| First pharmacophoric hypothesis for 5-HT7 antagonism. | LΓ³pez-RodrΓguez ML et al. | β | 2000 | β |
| Identification of the adenylyl cyclase-activating 5-hydroxytryptamine receptor subtypes expressed in the rat submandibular gland. | Bourdon DM et al. | β | 2000 | β |
| Smooth muscle layer-dependent distribution of 5-hydroxytryptamine(7) receptor in the porcine myometrium. | Kitazawa T et al. | β | 2000 | β |
| The pharmacology of headache. | Goadsby PJ | β | 2000 | β |
| The role of serotonin(2) receptors in mediating cocaine-induced convulsions. | O'Dell LE et al. | β | 2000 | β |
| 5-CT stimulation of adenylyl cyclase activity in guinea-pig hippocampus: evidence for involvement of 5-HT7 and 5-HT1A receptors. | Thomas DR et al. | β | 1999 | β |
| Allosteric regulation by oleamide of the binding properties of 5-hydroxytryptamine7 receptors. | Hedlund PB et al. | β | 1999 | β |
| A review of central 5-HT receptors and their function. | Barnes NM et al. | β | 1999 | β |
| Pindolol-insensitive [3H]-5-hydroxytryptamine binding in the rat hypothalamus; identity with 5-hydroxytryptamine7 receptors. | Clemett DA et al. | β | 1999 | β |
| Tetrahydrobenzindoles: selective antagonists of the 5-HT7 receptor. | Kikuchi C et al. | β | 1999 | β |
| A human serotonin-7 receptor pseudogene. | Qian IH et al. | β | 1998 | β |
| Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719. | Thomas DR et al. | β | 1998 | β |
| Gs protein-coupled serotonin receptors: receptor isoforms and functional differences. | Hamblin MW et al. | β | 1998 | β |
| Respiratory and cardiovascular effects of the mu-opioid receptor agonist [Lys7]dermorphin in awake rats. | Negri L et al. | β | 1998 | β |
| Role of serotonin in the immune system and in neuroimmune interactions. | MΓΆssner R et al. | β | 1998 | β |
| Selective labelling of 5-HT7 receptor recognition sites in rat brain using [3H]5-carboxamidotryptamine. | Stowe RL et al. | β | 1998 | β |
| Stimulation of type 1 and type 8 Ca2+/calmodulin-sensitive adenylyl cyclases by the Gs-coupled 5-hydroxytryptamine subtype 5-HT7A receptor. | Baker LP et al. | β | 1998 | β |